← FDA Drug Approvals (Drugs@FDA)

KAYEXALATE

NDA · New Drug Application · Sponsor: CONCORDIA · Approved 1958-06-05

Drug application

FDA Application #

NDA011287

Application type

New Drug Application

Brand name

KAYEXALATE

Generic name

Sodium Polystyrene Sulfonate

Active ingredients

SODIUM POLYSTYRENE SULFONATE

Dosage form

POWDER

Route

ORAL, RECTAL

Marketing status

Discontinued

Sponsor

CONCORDIA

First approval

1958-06-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown